HW Nijman

Immunologic aspect of ovarian cancer and p53 as tumor antigen

HW Nijman, Annechien J.A. Lambeck, SH van der Burg et al. · Journal of Translational Medicine · 2005 · 34 citations · Full text

Life Sciences, Immunology, Oncology +17

Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer

E. M. Dijkgraaf, Harry Hollema, MJP Welters et al. · OncoImmunology · 2014 · 32 citations · Full text

Medicine, Immunology, Oncology +17

Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer

CFM Molthoff, H. M. Pinedo, HMM Schlüper et al. · British Journal of Cancer · 1992 · 25 citations

Pharmacy, Oncology, Pharmacokinetics +13

L1CAM expression in uterine carcinosarcoma is limited to the epithelial component and may be involved in epithelial–mesenchymal transition

Annechien Plat, Marco de Bruyn, Xavier Matías‐Guiu et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2018 · 13 citations · Full text

Medicine, Oncology, Pathology +17